| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Rimegepant | (6S,9R)-6-(2,3-二氟苯基)-6,7,8,9-四氢-9-[[三异丙基硅烷基]氧基]-5H-环庚三烯并[B]吡啶-5-酮 | 1190363-46-2 |
| (R)-3-METHYLPIPERAZIN-2-ONE | (R)-3-甲基哌嗪-2-酮 | 922178-61-8 |
| Rimegepant | 1-(1-(1H-咪唑酸乙酯-1-羰基)吡啶-4-YL)-1H-咪唑[4,5-B]吡啶-2(3H)-酮 | 1373116-06-3 |
| (S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)piperidine-4-carboxamide | 1143534-59-1 | 1143534-59-1 |
| 3-Methyl-1,2,4-thiadiazole-5-carbohydrazide | 3-甲基-1,2,4-噻二唑-2(3H)-碳酰肼 | 1375066-73-1 |
| Zavegepant | 3-(哌啶-4-基)-1,2-二氢喹啉-2-酮盐酸 | 855778-84-6 |
| Elacestrant | 6-(2-氨基-4-甲氧基苯基)-5,6,7,8-四氢-2-萘酚 | 722520-36-7 |
| 4-nitroso-1,3-dihydroquinoxalin-2-one | 2(1H)-喹喔啉酮,3,4-二氢-4-亚硝基-(9CI) | 53374-52-0 |
| Elacestrant | 2-(4-甲酰基苯基)乙酸 | 34841-47-9 |
| Omaveloxolone (RTA 408) | NRF1-ACTIVATOR-1 | 1474034-05-3 |
| Deucravacitinib | 4,6-二羟基哒嗪-3-羧酸 | 1442437-21-9 |
| (S)-tert-butyl 4-(tert-butoxycarbonylamino)-4-(1-(4-chlorophenyl)-3-hydroxypropylcarbamoyl)piperidine-1-carboxylate | 1143534-57-9 | 1143534-57-9 |
| Deucravacitinib | 4,6-二氯哒嗪-3-羧酸锂水合物 | 2245111-15-1 |
| Anserine | 鹅肌肽 | 584-85-0 |
| Spermidine | 亚精胺 | 124-20-9 |
| Deucravacitinib | 2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺 | 1609394-10-6 |
| Rimegepant | (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ol | 1373116-05-2 |
| Deucravacitinib | 4,6-二氯-N-(甲基-d3)-3-哒嗪甲酰胺 | 1609393-89-6 |
| 4-Chloro-p-fluorobutyrophenone | 4-氯-4'-氟苯丁酮 | 3874-54-2 |
| Elacestrant | 6-苄氧基-3,4-二氢-2H-萘-1-酮 | 32263-70-0 |
| Infigratinib | 2,6-二氯-3,5-二甲氧基苯胺 | 872509-56-3 |
| 1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 2,3,6b,7,8,9,10,10a-octahydro-3-methyl-, (6bR,10aS) | (6BR,10AS)-3-甲基2,3,6B,7,8,9,10,10A八氢-1H-吡啶并[3' ,4' :4,5]吡咯并[1,2,3- DE]喹喔 | 313368-85-3 |
| (2S)-Hydroxy(phenyl)acetic acid-(4aS,9bR)-6-bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole (1:1) | (2S)-2-羟基-2-苯基乙酸；(4aS,9bR)-6-溴-1H,2H,3H,4H,4aH,5H,9bH-吡啶[4,3-b]吲哚 | 1059630-13-5 |
| 4-tert-butoxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester | 1-Boc-4-(Boc-氨基)哌啶-4-甲酸 | 189321-65-1 |
| Deucravacitinib | 2-甲氧基-3-硝基苯甲酸甲酯 | 90564-26-4 |
| Macitentan | 5-（4-溴苯基）-4,6-二氯嘧啶 | 146533-41-7 |
| phenyl N-[(E)-(5-nitrofuran-2-yl)methylideneamino]carbamate | 313369-25-4 | 313369-25-4 |
| N-Carbethoxy-4-piperidone | N-乙氧羰基-4-哌啶酮 | 29976-53-2 |
| Ectoine | 依克多因 | 96702-03-3 |
| Sodiumtetrahydrojasmonate | 四氢茉莉酸钠 | 1175006-92-4 |
| 2(1H)-Quinoxalinone,3,4-dihydro-; 1,2,3,4-Tetrahydro-2-quinoxali | 3,4-二氢-1H-喹噁啉-2-酮 | 59564-59-9 |
| Deucravacitinib | 2-甲氧基-3-硝基苯甲酰胺 | 722538-98-9 |
| Infigratinib | FGFR抑制剂(NVP-BGJ398) | 872511-34-7 |
| Infigratinib | N4-(4-(4-乙基哌嗪-1-基)苯基)-N6-甲基嘧啶-4,6-二胺 | 872511-35-8 |
| Deucravacitinib | 环丙酰胺 | 6228-73-5 |
| 7-methoxy-2,2-dimethylchroman-6-ylpalmitate | 二甲基色满棕榈酸酯美白剂 | 1105025-85-1 |
| 6-bromo-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride | 6-溴-2,3,4,5-四氢-1H-吡啶并[4,3-B]吲哚盐酸盐 | 1059630-11-3 |
| Calcifediol | 25-羟基维生素D3 | 19356-17-3 |
| Zavegepant | (2S)-2-氨基-3-(7-甲基-1H-吲唑-5-基)丙酸二盐酸 | 1414976-15-0 |
| METHYL 4-((TERT-BUTOXYCARBONYL)AMINO)PIPERIDINE-4-CARBOXYLATE | 4-N-BOC-哌啶-4-甲酸甲酯 | 115655-44-2 |
| (3S)-3-amino-3-(4-chlorophenyl)propanoic acid | (S)-3-氨基-3-(4-氯苯基)丙酸 | 131690-60-3 |
| Elacestrant | 4-甲氧基-2-硝基苯基硼酸 | 860034-09-9 |
| Deucravacitinib | 4,6-二氯哒嗪-3-羧酸乙酯 | 679406-03-2 |
| DIPALMITOYL HYDROXYPROLINE | 二棕榈酰羟脯氨酸 | 41672-81-5 |
| Deucravacitinib | 4,6-二羟基哒嗪-3-甲酸乙酯 | 1352925-63-3 |
| Macitentan | 5-(4-溴苯基)-6-羟基嘧啶-4(1H)-酮 | 706811-25-8 |
| Elacestrant | 7-苄氧基-3-溴-1,2-二氢萘 | 722536-73-4 |
| Deucravacitinib | 3-(2-甲氧基-3-硝基苯基)-1H-1,2,4-三唑 | 1609394-05-9 |
| Deucravacitinib | 3-(2-甲氧基-3-硝基苯基)-1-甲基-1H-1,2,4-三唑 | 1609394-08-2 |
| Cholesterol | 植物源胆固醇 | 57-88-5 |
| Fezolinetant | 1429560-52-0 | 1429560-52-0 |
| Lumateperone | 卢美哌隆杂质10 | 313369-16-3 |
| DIAMINOPYRIMIDINE OXIDE | 二氨基嘧啶氧化物 | |
| (3S)-3-amino-3-(4-chlorophenyl)propan-1-ol | (S)-对氯-Β-苯丙氨醇 | 886061-26-3 |
| Macitentan | N-[5-(4-溴苯基)-6-(2-羟基乙氧基)-4-嘧啶基]-N'-丙基氨基磺酰胺 | 1393813-43-8 |
| Infigratinib | 4-(4-乙基哌嗪-1-基)苯胺 | 115619-01-7 |
| (6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate | (6bR,10aS)-3-甲基-2,3,6b,7,10,10a-六氢-1H-吡啶并[3',4':4,5]吡咯并[1,2,3-de]喹喔啉-8(9H)-羧酸叔丁酯 | 313369-26-5 |
| Fisetin | 漆黄素 | 528-48-3 |
| Ergothioneine | 麦角硫因 | 497-30-3 |
| Deucravacitinib | 649729-45-3 | |
| Elacestrant | 2-溴-5-甲氧基苯胺 | 59557-92-5 |
| 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | 6-氯-7-氮杂嘌呤 | 3680-69-1 |
| Zavegepant | 3-(7-甲基-1H-吲唑-5-基)-2-氧代丙酸 | 868707-31-7 |
| Elacestrant | N-(2-(6--羟基-1,2,3,4-四氢萘-2-基)-5-(甲氧基苯基)乙酰胺 | 722520-42-5 |
| (3R)-4-[(2,4-dimethoxyphenyl)methyl]-3-methylpiperazin-2-one | (R)-3-甲基-4-(2,4-二甲氧基苄基)哌嗪-2-酮 | 1383146-20-0 |
| Macitentan | N-[5-(4-溴苯基)-6-氯-4-嘧啶基]-N'-丙基氨基磺酰胺 | 1393813-42-7 |
| 1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,9,10-tetrahydro-2-oxo-, ethyl ester | 2-氧代-2,3,9,10-四氢-1H-吡啶[3',4':4,5]吡咯并[1,2,3-DE]喹喔啉-8(7H)-羧酸乙酯 | 313544-31-9 |
| Deucravacitinib | BMS-986165 Related Compound 6 | 1609394-23-1 |
联系方式
